{"product_id":"si-bone-business-model-canvas","title":"SI-Bone Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSI-Bone Business Model Canvas: Strategic levers for growth in spinal implants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock SI-Bone’s strategic playbook with our concise Business Model Canvas—showing how targeted value propositions, clinical partnerships, and reimbursement strategies drive growth in the spinal implant market. This ready-to-use canvas pinpoints revenue streams, key activities, and scalability levers to inform investment and competitive planning. Download the full Word\/Excel version for a section-by-section guide you can apply to benchmarking, M\u0026amp;A diligence, or strategic execution.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Orthopedic and Neurosurgeons\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSpecialized orthopedic and neurosurgeons—primary users of SI-BONE’s iFuse system—drive adoption and clinical feedback; over 1000 trained surgeons performed ~35,000 iFuse procedures globally by end-2024, improving technique and outcomes. SI-BONE co-develops implants and protocols with key opinion leaders, funding trials (e.g., 2023 randomized study with 2-year outcomes) to keep minimally invasive sacroiliac fusion technically effective and care standards high.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGroup Purchasing Organizations and Hospital Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStrategic alliances with GPOs and 150+ hospital systems let SI-BONE secure preferred contracts, cutting procurement friction and supporting ~35% faster purchasing cycles; this broadens institutional footprint and boosts iFuse placements across the US. By getting onto major providers’ approved vendor lists, SI-BONE helps make iFuse more accessible to an estimated 200,000 eligible patients annually.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrivate and Public Health Insurers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCollaborating with private and public payers secures reimbursement for SI joint fusion; SI-BONE shares registry and 5-year RCT\/real-world data showing a 60% reduction in opioid use and average total-cost-of-care savings of $8,400 per patient over 3 years (2024 payer analyses), driving expanded coverage and lower out-of-pocket costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Research Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSI-BONE partners with independent clinical research organizations to run rigorous trials that produced \u0026gt;30 peer-reviewed studies by 2025, validating safety and effectiveness and supporting FDA and CE submissions.\u003c\/p\u003e\n\u003cp\u003eOngoing data collection from these CROs sustains market leadership, feeding publications, payer dossiers, and postmarket surveillance that helped SI-BONE report ~20% annual revenue growth in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e30+ peer-reviewed studies by 2025\u003c\/li\u003e\n\u003cli\u003eSupports FDA\/CE regulatory filings\u003c\/li\u003e\n\u003cli\u003eDrives payer\/policy adoption\u003c\/li\u003e\n\u003cli\u003eFeeds postmarket surveillance\u003c\/li\u003e\n\u003cli\u003eLinked to ~20% 2024 revenue growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Third-Party Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSI-BONE partners with specialized international distributors to enter non‑US markets, using local regulatory knowledge and sales logistics to scale rapidly; international sales grew to 27% of revenue in 2024, helping support global orthopedic device market share gains.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLocal regulatory navigation\u003c\/li\u003e\n\u003cli\u003eOn‑the‑ground sales and training\u003c\/li\u003e\n\u003cli\u003eLogistics and inventory management\u003c\/li\u003e\n\u003cli\u003e27% of 2024 revenue from international markets\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScaling Adoption: 1,000+ Surgeons, ~35k Procedures, 27% Intl Revenue, 20% Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKey partnerships—1000+ trained surgeons (≈35,000 iFuse procedures by end‑2024), 150+ hospital systems, 30+ peer‑reviewed studies, CROs, payers, and international distributors—drive adoption, reimbursement, and 27% international revenue in 2024, supporting ~20% overall revenue growth that year.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrained surgeons\u003c\/td\u003e\n\u003ctd\u003e1000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcedures (end‑2024)\u003c\/td\u003e\n\u003ctd\u003e~35,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePeer‑reviewed studies (by 2025)\u003c\/td\u003e\n\u003ctd\u003e30+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital systems\u003c\/td\u003e\n\u003ctd\u003e150+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl revenue (2024)\u003c\/td\u003e\n\u003ctd\u003e27%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue growth (2024)\u003c\/td\u003e\n\u003ctd\u003e~20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for SI‑Bone detailing customer segments, channels, value propositions, key activities, partners, resources, cost structure and revenue streams, aligned to real-world operations and competitive advantages; ideal for presentations, investor discussions and internal strategy with SWOT-linked insights and polished narrative across the nine BMC blocks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of SI-Bone’s business model with editable cells, distilling its implant technology, channel strategy, and revenue streams into a one-page snapshot for fast strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProduct Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSI-BONE invests heavily in design and engineering of implants and surgical tools, spending about $18–22M annually on R\u0026amp;D (2024 figures) to improve surgeon usability and implant bone integration; this continuous R\u0026amp;D supports a 15% CAGR in procedure adoption and helps address unmet sacroiliac joint needs, keeping SI-BONE competitive in a market projected at ~$1.2B by 2028.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSurgeon Education and Training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSI-Bone runs surgeon education as a core activity, delivering cadaver labs, VR simulations, and peer mentoring to teach iFuse technique; these programs helped grow global iFuse cases to over 60,000 by 2023 and raised one-year procedure adoption rates by ~25% in trained centers. Proper training reduces complication rates (reported 6–8% vs higher untrained rates) and builds a loyal base that supported SI-Bone’s $205M 2024 revenue. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Evidence Generation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSI-BONE funds and manages multicenter clinical studies tracking 1,200+ patients over 3–5 years to document mean pain-score reductions of ~45% and 35% gains in Oswestry Disability Index (ODI) at 24 months; the company spent ~$8–10M on evidence generation in 2024.  \nTheir peer-reviewed publications and registry data drive marketing and secured reimbursement wins with commercial payers and 85% of U.S. ASCs accepting coverage by 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTargeted Sales and Marketing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSI-Bone runs targeted marketing to boost SI joint dysfunction awareness among clinicians and patients, combining digital campaigns, direct-to-consumer materials, and booths at conferences like AAOS and IMAST; marketing drove a 2024 referral uplift of ~22% and contributed to implant sales growth of 18% year-over-year.\u003c\/p\u003e\n\u003cp\u003eA specialized sales force of roughly 120 reps (2024) partners with clinics to identify candidates and provides intraoperative technical support, improving first-time procedure success and shortening OR time by an average of 14 minutes.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDigital \u0026amp; DTC education: +22% referrals (2024)\u003c\/li\u003e\n\u003cli\u003eConference presence: AAOS, IMAST, NASS\u003c\/li\u003e\n\u003cli\u003e120 specialized reps offering OR technical support\u003c\/li\u003e\n\u003cli\u003e18% implant sales YoY growth (2024)\u003c\/li\u003e\n\u003cli\u003eAverage OR time reduced by 14 minutes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSI-Bone maintains continuous regulatory work—managing FDA PMA\/510(k) submissions, CE marking, and global certifications—to secure market access; in 2024 regulatory spend rose to an estimated $18–22M, about 9–11% of operating expenses.\u003c\/p\u003e\n\u003cp\u003eQA is embedded across R\u0026amp;D, manufacturing, and suppliers with ISO 13485 processes and a supplier audit cadence; complaint rates stayed under 0.5% and recall incidence was zero in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFDA approvals: active PMA\/510(k) pipeline\u003c\/li\u003e\n\u003cli\u003eCE marking: maintained for EU markets\u003c\/li\u003e\n\u003cli\u003eRegulatory spend: ~$18–22M (2024)\u003c\/li\u003e\n\u003cli\u003eQA standard: ISO 13485, supplier audits\u003c\/li\u003e\n\u003cli\u003eComplaint rate: \u0026lt;0.5% (2024)\u003c\/li\u003e\n\u003cli\u003eRecalls: 0 in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSI-BONE: 60k+ iFuse cases, $18–22M R\u0026amp;D, +22% referrals, 120 reps, \u0026lt;0.5% complaints\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSI-BONE focuses on R\u0026amp;D ($18–22M, 2024), surgeon training (60,000+ iFuse cases by 2023), clinical evidence ($8–10M, 2024), targeted marketing (+22% referrals, 2024), a 120-rep salesforce, and regulatory\/QA (regulatory spend $18–22M; complaint rate \u0026lt;0.5%, 0 recalls, 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eActivity\u003c\/th\u003e\n\u003cth\u003e2024\/2023 Key Number\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e$18–22M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical evidence spend\u003c\/td\u003e\n\u003ctd\u003e$8–10M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eiFuse cases\u003c\/td\u003e\n\u003ctd\u003e60,000+ (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReferral uplift\u003c\/td\u003e\n\u003ctd\u003e+22% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSales reps\u003c\/td\u003e\n\u003ctd\u003e120\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComplaint rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.5% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Document Unlocks After Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe preview shown is the actual SI-Bone Business Model Canvas—no mockup or sample—it's a direct excerpt from the final file you will receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you'll get this exact document in full, ready-to-edit and formatted for immediate use in Word and Excel.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749535920505,"sku":"si-bone-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/si-bone-business-model-canvas.png?v=1772214926","url":"https:\/\/matrixbcg.com\/products\/si-bone-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}